Pharmaceutical filing citing Diabetes Obesity and Metabolism paper — Bio-path, 2024-12-12
Bio-pathBio-pathOTC BPTH
Filings SEC · Quote Google cited a paper published in Diabetes Obesity and Metabolism in its regulatory filing with the U.S. Securities and Exchange CommissionU.S. Securities and Exchange Commission
Regulator · Website as a basis for its claims. The company read the manner in which it wrote the paper and the scope the paper actually demonstrated in sequence. It described where the stock price movement over the following month compared to past cases of the same type. This is a retrospective judgment written after knowing the results. The paper was read only up to the abstract.
The disclosure wrote the paper in the press release like this
When a U.S. listed company has something to inform shareholders, the report submitted to the Securities and Exchange Commission is called 8-K. The item numbers of the document submitted by Bio-path on 2024-12-12 were 7.01 Reg FD public · 9.01 financial statements · attached documents. The company cited a paper published in Diabetes Obesity and Metabolism in the attached press release. The sentence citing the paper, copied verbatim from the original, is as follows.
The role of GRB2 in diabetes, diabetes complications and related disorders. Diabetes Obes Metab (2024) 1–12. doi: 10.1111/dom.16015 Shen X, Miao Y, Feng R, et al.
What readers should look at first is where the company placed the paper in the press release. Next is to determine whether the paper supports the entire company claim or only part of it. To answer the latter question, one must read the full paper. This article, which only read the abstract, cannot answer that.
The scope of the paper mentioned in the abstract is up to here.
The paper title is The role of GRB2 in diabetes, diabetes complications and related disorders and it was published in Diabetes Obesity and Metabolism on 2024-10-30. The authors' affiliations are Gansu Provincial Hospital · First Hospital of Lanzhou University · Lanzhou University · Ningxia Medical University. The summary published at the beginning of the paper is called abstract. What this article read was only up to there. This paragraph was rewritten by a person after filtering a draft written by a machine reading the abstract through numerical comparison, so it is of a different grade from a full-text reading and a definitive judgment.
This paper is a review that compiles and summarizes existing results, not a study based on new experiments. The protein GRB2 serves as an adapter that connects to various signaling pathways within cells. The paper briefly examines how the disruption of this regulation is linked to diabetes and its complications. Evidence is collected showing that the GRB2 pathway is involved in insulin resistance, inflammation, neuropathy, nephropathy, and retinopathy. The authors themselves note that the role of GRB2 remains largely unknown.
What the abstract does not answer remains in the full text and appendices. This article leaves gaps as gaps. Readers must compare the two citations to determine which sentence in the abstract corresponds to the excerpt cited by the company.
One month later, the stock price was within the top quarter of the sample.
The remaining return after subtracting the portion attributable to market movement is called excess return. Dates are counted only on days when the stock market is open, referred to as trading days. In calendar terms, 20 trading days is approximately one month. The excess return on the day of the filing and for the following month are listed in the table below.
| Period | Excess return relative to the market | Meaning |
|---|---|---|
| Five trading days before the filing | +6.9% | The extent of movement before the filing |
| On the filing date | −0.8% | On the filing date or the first trading day thereafter |
| Cumulative over +1 to +5 trading days | +122.1% | One week |
| Cumulative over +1 to +20 trading days | +69.5% | One month |
A bundle of past cases of the same type is called a sample. The position counted from the bottom is expressed as a percentile. The one-month excess return of +69.5% in this case is in the top quarter, corresponding to the 100% position from the bottom among 142 samples.
| Sample scale (20 trading days) | Tenth from the bottom | Fourth from the bottom | Median | Top 25% | Top 10% | This case |
|---|---|---|---|---|---|---|
| Excess return | −31.9% | −20.1% | −7.4% | +5.5% | +18.7% | +69.5% |
Half of the sample falls between the two central marks on the graph. One checks whether this case lies within or outside the range on the graph. The sample consists of cases where U.S.-listed companies cited papers in 8-K filings over the past decade. The company itself is excluded from the sample. The numbers listed here are past facts, not rules applicable to future cases.
After the filing, the company issued such documents.
Three 8-K filings issued by the company after the filing date are listed by item number only. In 8-K filings without titles, the item numbers indicate the type of content. Whether it was an earnings announcement or a contract can be identified by the number. The specific event is read in the original text via each link.
- 2024-12-13 8-K Items 3.01, 5.02, 5.07, 9.01 — Executive/Board Changes, Shareholders' Meeting Results, Financial Statements, Attached Documents
- 2024-12-19 8-K Items 7.01, 9.01 — Reg FD Disclosure, Financial Statements, Attached Documents
- 2025-01-10 8-K Items 7.01, 9.01 — Reg FD Disclosure, Financial Statements, Attached Documents
What this article does not answer
This article, based only on abstracts, does not answer what methods the paper used, what it reviewed, or how far it demonstrated. How many times the cited paper was subsequently cited can be verified again via the citation count on OpenAlexOpenAlex
Data source · Website. What will be examined next is whether the company's next 8-K filing cites the same paper again.
Glossary
- 8-K
- A voluntary report submitted to the Securities and Exchange Commission when a U.S. listed company has something to inform shareholders. The type is indicated by item numbers such as earnings, contracts, and executive changes. All events in this article come from this document.
- Excess return
- The remainder after subtracting the overall market return from the stock return. It is used to see the movement of the company alone by removing the part where the market rises and falls together.
- Trading day
- A date counting only the days the stock market is open. Since weekends and holidays are excluded, 20 trading days are about a month in the calendar.
- Sample and percentile
- A bundle of past cases of the same type is a sample, and the position from the bottom within it is expressed as a percentile. A percentile of 10 means that nine out of ten cases performed better than this case.
- Abstract
- A summary placed at the beginning of a paper. The author writes in a few sentences what was done, how it was done, and what results were obtained. Without reading the full text, one cannot know the details and limitations of the method.